Australia Legal Cannabis Market Analysis, Drivers, Restraints, Opportunities, Threats, Trends, Applications, and Growth Forecast to 2029
“Australia Legal Cannabis Market” is the title of an upcoming report offered by MarketResearch.Biz. The report contains information and data, and inputs from both primary and secondary data sources, that have been verified and validated by experts in the target market. The report presents a thorough study of revenues, historical data, and information, key developments, and strategies by major players that offer vital insights and perspectives in various scenarios market. Besides critical data and related information, the report includes key trends (both present and future), factors that are driving market growth, factors that are or could be potential restraints to market growth, as well as opportunities that can be leveraged for potential revenue generation in untapped areas. It also covers threats or challenges for existing as well as new entrants in the market. The Australian legal cannabis market has been segmented on the basis of product type, as well as application.
Medical marijuana or medical cannabis, is cannabis and cannabinoids that are prescribed by physicians for their patients to treat ailments. Australia first legalized medical marijuana at a federal level in 2016. In 2019, Canberra became the continent’s first city to legalize the cultivation and possession of marijuana for adult consumption.
The use of marijuana in Australia, at a federal level, is illegal. However, according to the new cannabis laws that have been passed by the Australian government allowed for the cultivation and possession of marijuana in the Australian Capital Territory (ACT). What this implies is that, residents of the city of Canberra are now able to cultivate two cannabis plants and possess up to 50 grams or 1.76 oz. of marijuana. It appears that many of the other states will be following suite in legalizing the use of marijuana for recreational purposes. This is a primary factor that is expected to significantly impact the revenue growth of Australia’s legal cannabis market in the years to come.
The process of presently accessing medical hemp oil in Australia is a tedious and expensive feat, as no cannabidiol (CBD) /hemp products have been approved by the Therapeutic Goods Administration (TGA). Patients that wish to purchase these products, must first apply and qualify for them through the Australian government’s special access scheme. This factor could potentially restrain future revenue growth of Australia’s legal cannabis market. Additionally, the rising illicit cannabis trade is another factor that is impacting the revenue growth of this global market.
Segmentation of the Australia legal cannabis market is as follows:
In terms of product type, the marijuana flower segment accounted for the majority revenue share of the Australia legal cannabis market in 2019, owing to the large population of cannabis smokers and its widespread availability. Although, the oil segment is expected to index the fastest rate of revenue growth of this global market in the foreseeable future.
On the basis of application, the market is classified into adult use, medical, and B2B sales. The medical application segment held the highest number of shares of the Australian market, owing to the increasing awareness of medical cannabis products.
Segmentation of the Australia Legal Cannabis Market:
Segmentation by Product Type:
- Hemp Oil
Segmentation by Application:
- Adult Use
- Chronic Pain
- Sleep Disorder
- B2B Channels
Attribute Report Details Market Size Ask For Market Size Growth Rate Ask For Growth Rate Key Companies Ask For Companies Report Coverage Revenue analysis, Competitive landscape, Key company analysis, Market Trends, Key segments, Distribution Channel, Market Dynamics, COVID-19 Impact Analysis and more… Historical Data Period 2015-2020 Base Year 2022 Forecast Period 2022-2031 Region Scope North America, Europe, Asia-Pacific, South America, Middle East & Africa Country Scope United States, Canada and Mexico, Germany, France, UK, Russia and Italy, China, Japan, Korea, India and Southeast Asia, Brazil, Argentina, Colombia etc.Saudi Arabia, UAE, Egypt, Nigeria and South Africa Revenue in US$ Mn
- AusCann Group Holdings Pty Ltd
- Cann Group Ltd
- Bod Australia
- Zelira Therapeutics
- Althea Group Holdings Limited
- THC Global Group Limited
- MGC Pharmaceuticals Ltd
- Ecofibre Limited
Request for TOC
Why Choose Us
- 360 Degree Approach
- Growth Consulting
- 24/7 Research Support
- Comprehensive-Level of Customization
- Comprehensive-Level of Customization
- Competitive Intelligence
- Single-Country/ Region Intelligence
- Post-Sale Service Assistance
- Access to Lead Analysts
- Available in PDF, Excel, Word/ PPT
Request for Customization
Don't just take our word. We are trusted by these great companies!